NCT00891878 2018-07-24
Capecitabine With or Without Sunitinib Malate as First-Line Therapy in Treating Patients With Metastatic Cancer of the Esophagus or Gastroesophageal Junction
Alliance for Clinical Trials in Oncology
Phase 2 Completed
Clinical Trials
4 trialsNCT00400114 2017-05-08
Sutent Following Chemotherapy, Radiation and Surgery For Resectable Esophageal Cancer
University Health Network, Toronto
Phase 2 Completed
NCT00702884 2017-03-21
Sunitinib in Treating Patients With Relapsed or Refractory Esophageal or Gastroesophageal Junction Cancer
Ohio State University Comprehensive Cancer Center
Phase 2 Completed
NCT00730353 2017-03-16
Sutent + Taxol for Advanced Esophageal Cancer
Hoosier Cancer Research Network
Phase 2 Completed